Correlation Between Clal Biotechnology and Israel Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Israel Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Israel Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Israel Corp, you can compare the effects of market volatilities on Clal Biotechnology and Israel Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Israel Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Israel Corp.

Diversification Opportunities for Clal Biotechnology and Israel Corp

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Clal and Israel is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Israel Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Israel Corp and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Israel Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Israel Corp has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Israel Corp go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Israel Corp

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Israel Corp. But the stock apears to be less risky and, when comparing its historical volatility, Clal Biotechnology Industries is 1.06 times less risky than Israel Corp. The stock trades about -0.07 of its potential returns per unit of risk. The Israel Corp is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  7,398,000  in Israel Corp on September 14, 2024 and sell it today you would earn a total of  2,491,000  from holding Israel Corp or generate 33.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Israel Corp

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Israel Corp 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Israel Corp are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Israel Corp sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Israel Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Israel Corp

The main advantage of trading using opposite Clal Biotechnology and Israel Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Israel Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Israel Corp will offset losses from the drop in Israel Corp's long position.
The idea behind Clal Biotechnology Industries and Israel Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities